Anpario plc (AIM:ANP)

Market Cap	79.74M
Revenue (ttm)	38.20M
Net Income (ttm)	4.11M
Shares Out	20.45M
EPS (ttm)	0.24
PE Ratio	15.97
Forward PE	12.75
Dividend	0.11 (2.88%)
Ex-Dividend Date	Jul 10, 2025

Volume	17,083
Average Volume	77,308
Open	391.45
Previous Close	390.00
Day's Range	388.52 - 391.45
52-Week Range	241.00 - 488.55
Beta	0.69
RSI	49.71
Earnings Date	Mar 26, 2025

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 157
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.